Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In the last ten years FDA made 8 decisions for Dt Medtech (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2021 (2). The latest was on 2026-07-31.
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-07-31 | PMA | P160036-S008 | Hintermann Series H3 Total Ankle Replacement System · Postapproval Study Protocol |
| 2024-09-20 | PMA | P160036-S005 | Hintermann Series H3 Total Ankle Replacement System · Postapproval Study Protocol |
| 2023-11-06 | PMA | P160036-S004 | Hintermann Series H3 Total Ankle Replacement System · Change Design/Components/Specifications/Material |
| 2021-10-15 | PMA | P160036-S003 | Hintermann Series H3 Total Ankle Replacement System · Postapproval Study Protocol |
| 2021-03-11 | PMA | P160036-S002 | Hintermann Series H3 Total Ankle Replacement System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Dt Medtech.